SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-009157
Filing Date
2015-06-04
Accepted
2015-06-04 16:12:49
Documents
1
Period of Report
2015-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3397
  Complete submission text file 0001179110-15-009157.txt   4801
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
Aguiar Michael W (Reporting) CIK: 0001318005 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 15913171